Article Details

AEON Biopharma Investors Contribute Additional $20 Million to SPAC Deal

Retrieved on: 2023-01-10 23:37:03

Tags for this article:

Click the tags to see associated articles and topics

AEON Biopharma Investors Contribute Additional $20 Million to SPAC Deal. View article details on hiswai:

Excerpt

By IPO Edge Editorial Staff Biopharmaceutical company AEON Biopharma, Inc. has raised an additional $20 million in funding from existing investors ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up